Inhibition of the Semaphorin 4D-Plexin-B1 axis prevents calcification in vascular smooth muscle cells

BMB Rep. 2023 Mar;56(2):160-165. doi: 10.5483/BMBRep.2022-0165.

Abstract

Vascular calcification is common in cardiovascular diseases including atherosclerosis, and is associated with an increased risk of pathological events and mortality. Some semaphorin family members play an important role in atherosclerosis. In the present study, we show that Semaphorin 4D/Sema4D and its Plexin-B1 receptor were significantly upregulated in calcified aorta of a rat chronic kidney disease model. Significantly higher Sema4D and Plexin-B1 expression was also observed during inorganic phosphate-induced calcification of vascular smooth muscle cells. Knockdown of Sema4D or Plexin-B1 genes attenuated both the phosphate-induced osteogenic phenotype of vascular smooth muscle cells, through regulation of SMAD1/5 signaling, as well as apoptosis of vascular smooth muscle cells, through modulation of the Gas6/Axl/Akt survival pathway. Taken together, our results offer new insights on the role of Sema4D and Plexin-B1 as potential therapeutic targets against vascular calcification. [BMB Reports 2023; 56(3): 160-165].

Publication types

  • News

MeSH terms

  • Animals
  • Muscle, Smooth, Vascular / metabolism
  • Rats
  • Receptors, Cell Surface / metabolism
  • Semaphorins* / genetics
  • Semaphorins* / metabolism
  • Semaphorins* / pharmacology
  • Vascular Calcification*

Substances

  • CD100 antigen
  • plexin
  • Receptors, Cell Surface
  • Semaphorins

Grants and funding

ACKNOWLEDGEMENTS This research was supported by grants from the National Research Foundation of Korea funded by the Korean government (MSIT, NRF-2018R1A5A2023879 and 2021R1A2C1003687).